Skip to main content

Sir Tadataka Yamada

Life Sciences Team Venture Partner & Growth Buyout Team Senior Advisor, Frazier Healthcare Partners

Sir Tadataka Yamada

Residency: Oct. 3-7, 2016

Public Talk:
"Biomedical Research: Lessons from Global Health"
Oct. 5, 2016
Sir Tadataka Yamada, the former director of the Bill & Melinda Gates Foundation Global Health Program, discussed key global health issues and current trends of biomedical research and its impact.


Sir Tadataka Yamada is the life sciences team venture partner and growth buyout team senior advisor at Frazier Healthcare Partners. Before his current role, Sir Yamada was the chairman of research and development at GlaxoSmithKline PLC, director of global health at the Bill & Melinda Gates Foundation, as well as chief scientific officer at Takeda Pharmaceuticals Co. in Tokyo. As an extension of his work in entrepreneurship and medical development, Sir Yamada emphasizes the power of partnerships in health care between large pharmaceutical companies and philanthropic foundations.

During his residency, Sir Yamada held several meetings within the UC San Diego community, including GPS faculty and student groups, JFIT, Department of Bioengineering, School of Medicine and Skaggs School of Pharmacy. In addition to presenting a public talk on “Biomedical Research: Lessons from Global Health,” Sir Yamada had several high-level meetings with major private companies and institutes such as Qualcomm Inc., J. Craig Venter Institute, Sanford Burnham Prebys Medical Discovery Institute, aTyr Pharma Inc. and PvP Biologics.